• MnTBAP Chloride: From Redox Biology to Translation

  2026-09-12

  MnTBAP Chloride offers a mechanism-led way to interrogate how mitochondrial superoxide connects oxidative stress with inflammation, mitochondrial dysfunction, and stress-related phenotypes. This article places the compound’s endothelial, inflammatory, and chronic-stress evidence into a translational framework for designing stronger preclinical studies.

• Ceftolozane Sulfate: Assay-to-PK/PD Workflow

  2026-09-11

  Build a practical pipeline from broth microdilution and time-kill testing to neutropenic mouse thigh infection model design with Ceftolozane sulfate. The workflow emphasizes isolate-specific MIC interpretation, AmpC-aware resistance analysis, and exposure targets based on free-drug time above MIC.

• Chlorambucil: Reading DNA Damage in Cell Assays

  2026-09-11

  Chlorambucil is a nitrogen mustard alkylating agent whose effects can be misread when growth inhibition is treated as equivalent to cell death. This article applies a response-phenotyping framework to improve DNA damage, apoptosis, and cytotoxicity assay interpretation across cancer models.

• Palonosetron and Chemotherapy-Induced Nausea

  2026-09-10

  Ruhlmann and Herrstedt’s review examines how palonosetron’s long receptor residence, high 5-HT3 affinity, allosteric binding, and positive cooperativity may influence prevention of chemotherapy-induced nausea and vomiting. Its central practical message is that pharmacologic distinctions matter only when they improve control of acute or delayed symptoms, tolerability, or treatment implementation.

• Indazole and Indole Glucagon Receptor Antagonists

  2026-09-10

  The 2015 Bioorganic & Medicinal Chemistry Letters study describes a novel indazole- and indole-based series of glucagon receptor antagonists derived from the earlier MK-0893 program. Systematic SAR exploration produced compounds with strong in vitro activity, favorable rat pharmacokinetics, and oral efficacy for GRA 16d in humanized glucagon receptor mouse models.

• ECL Chemiluminescent Substrate Detection Kit

  2026-09-09

  The hypersensitive ECL Chemiluminescent Substrate Detection Kit supports low-abundance protein analysis when conventional western blot signals are difficult to resolve. Its low-picogram sensitivity, reduced background, and extended signal window make it especially useful for validating inflammatory pathway proteins alongside RNA-focused experiments.

• Reactive Oxygen Species Assay Kit: DHE Workflow

  2026-09-09

  Build a practical live-cell superoxide workflow around the Reactive Oxygen Species Assay Kit (DHE), from plate setup to signal normalization and troubleshooting. The approach translates shionone–mitophagy findings in pulmonary fibrosis into testable oxidative-stress experiments without treating fluorescence as a stand-alone proof of mechanism.

• Podophyllotoxin Assay Workflows That Reproduce

  2026-09-08

  A scenario-driven guide to improving cell viability, proliferation, and cytotoxicity assays with Podophyllotoxin SKU N1790. It connects compound handling, microtubule-directed biology, orthogonal readouts, and practical vendor-selection criteria for more interpretable cancer research data.

• SU5416 (Semaxanib) in Cell Assays

  2026-09-08

  This scenario-based guide explains how SU5416 (Semaxanib), SKU A3847, can improve the interpretation and reproducibility of VEGFR2-focused viability, proliferation, and angiogenesis assays. It covers assay confounding, dosing, DMSO handling, pathway controls, data interpretation, and practical supplier-selection criteria.

• Atrial Natriuretic Peptide: Bench Workflow

  2026-09-07

  Build reproducible ANP experiments around acute vascular, renal, and metabolic readouts rather than relying on a single endpoint. This workflow also shows how findings from an adiponectin neuroinflammation study can inform control design without confusing adiponectin with ANP.

• MCL-1’s Canonical Apoptotic Role in Breast Cancer

  2026-09-07

  The reference study shows that established breast tumors depend on MCL-1 primarily because of its canonical anti-apoptotic activity, rather than because of a non-apoptotic function. Genetic deletion and pharmacological inhibition both required BAX/BAK to produce tumor control, providing a mechanistic framework for interpreting MCL-1-targeted therapy and related apoptosis studies.

• Vincristine Sulfate: Mechanism to Translation

  2026-09-05

  A translational perspective on vincristine sulfate that connects microtubule dynamics, assay design, disease modeling, product handling, and evidence discipline for cancer research.

• SP2509: Lysine-Specific Demethylase 1 Antagonist

  2026-09-04

  SP2509 is a potent Lysine-specific demethylase 1 antagonist for experimental cancer epigenetics and acute myeloid leukemia research. Supplier-reported studies associate LSD1 blockade with increased promoter H3K4Me3, AML differentiation, apoptosis induction, and prolonged survival in an AML xenograft model.

• Trelagliptin and Cognitive Impairment in Diabetic Rats

  2026-09-04

  The reference study shows that trelagliptin improved learning, memory, neuronal structure, and synaptic plasticity in rats with diabetes-related cognitive impairment. Its findings associate these effects with suppression of inflammatory signaling and activation of the PI3K/Akt/GSK-3β pathway, providing a preclinical rationale for investigating DPP-4 inhibition beyond glycemic control.

• NF-κB/Apaf1 Axis in Septic Acute Kidney Injury

  2026-09-03

  This 2026 study identifies an NF-κB/Apaf1/caspase-9 sequence that suppresses autophagy while promoting tubular inflammation and apoptosis in septic acute kidney injury. Genetic and pharmacological experiments position Apaf1 and caspase-9 as mechanistic links between inflammatory signaling and proximal tubular damage, providing a framework for testing upstream NF-κB perturbation strategies.

8537 records 1/570 page Next 12345 下5页 Last page